TScan Therapeutics, Inc. (TCRX) NASDAQ
0.98
-0.03(-2.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.98
-0.03(-2.97%)
Currency In USD
| Market Cap | 129.86M |
| Enterprise Value | 71.59M |
| P/E Ratio | -1.02 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 6.55 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | -0.91 |
| Enterprise/EBITDA | 0.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -13.61 |
| Operating Margin | -14.09 |
| Return On Assets | -0.62 |
| Return On Equity | -0.92 |
| Revenue | 10.33M |
| Revenue/Share | 0.07 |
| Gross Profit | 7.46M |
| EBITDA | -132.95M |
| Net Income | -129.77M |
| Diluted EPS | -1 |
| Total Cash | 128.06M |
| Total Cash/Share | 0.99 |
| Total Debt | 59.88M |
| Total Debt/Equity | 0.62 |
| Current Ratio | 6.65 |
| Book Value Per Share | 0.75 |
| 52-Week Change | -32.88 |
| 52-Week High | 2.57 |
| 52-Week Low | 0.88 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.32 |
| Average Volume | 865,263 |
| Shares Outstanding | 61.07M |
| % Held by Institutions | 24.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |